Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond

Metabolism 2026

View at publisher
Authors: Emir Muzurović, Niki Katsiki, Špela Volčanšek, Fulvio Plescia, Manfredi Rizzo, Christos S. Mantzoros
DOI: 10.1016/j.metabol.2026.156494
Cited by: 20
References: 289

Fields of Study & Subjects

Diabetes Treatment and Management Bariatric Surgery and Outcomes Regulation of Appetite and Obesity

Publication details

Journal / source
Metabolism
Publisher
Elsevier BV
Volume
177
Pages
156494–156494
Publication date
20 January 2026
Language
EN